Literature DB >> 11779501

Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis.

I Irminger-Finger1, W C Leung, J Li, M Dubois-Dauphin, J Harb, A Feki, C E Jefford, J V Soriano, M Jaconi, R Montesano, K H Krause.   

Abstract

The BRCA1-associated protein BARD1 is a putative tumor suppressor. We suggest that BARD1 is a mediator of apoptosis since (1) cell death in vivo (ischemic stroke) and in vitro is accompanied by increased levels of BARD1 protein and mRNA; (2) overexpression of BARD1 induces cell death with all features of apoptosis; and (3) BARD1-repressed cells are defective for the apoptotic response to genotoxic stress. The proapoptotic activity of BARD1 involves binding to and elevations of p53. BRCA1 is not required for but partially counteracts apoptosis induction by BARD1. A tumor-associated mutation Q564H of BARD1 is defective in apoptosis induction, thus suggesting a role of BARD1 in tumor suppression by mediating the signaling from proapoptotic stress toward induction of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11779501     DOI: 10.1016/s1097-2765(01)00406-3

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  38 in total

1.  BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets.

Authors:  Timothy K MacLachlan; Rishu Takimoto; Wafik S El-Deiry
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Quantitative proteomic identification of the BRCA1 ubiquitination substrates.

Authors:  Meihua Song; Kevin Hakala; Susan T Weintraub; Yuzuru Shiio
Journal:  J Proteome Res       Date:  2011-10-11       Impact factor: 4.466

3.  Estrogen receptor alpha regulates expression of the breast cancer 1 associated ring domain 1 (BARD1) gene through intronic DNA sequence.

Authors:  Amy L Creekmore; Yvonne S Ziegler; Jamie L Bonéy; Ann M Nardulli
Journal:  Mol Cell Endocrinol       Date:  2007-01-16       Impact factor: 4.102

4.  Crystal structure of the BARD1 ankyrin repeat domain and its functional consequences.

Authors:  David Fox; Isolde Le Trong; Ponni Rajagopal; Peter S Brzovic; Ronald E Stenkamp; Rachel E Klevit
Journal:  J Biol Chem       Date:  2008-05-14       Impact factor: 5.157

5.  Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies.

Authors:  S-M Karppinen; R B Barkardottir; K Backenhorn; T Sydenham; K Syrjäkoski; J Schleutker; T Ikonen; K Pylkäs; K Rapakko; H Erkko; G Johannesdottir; A-M Gerdes; M Thomassen; B A Agnarsson; M Grip; A Kallioniemi; J Kere; L A Aaltonen; A Arason; P Møller; T A Kruse; A Borg; R Winqvist
Journal:  J Med Genet       Date:  2006-07-06       Impact factor: 6.318

6.  Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability.

Authors:  Ellen E McCarthy; Julide T Celebi; Richard Baer; Thomas Ludwig
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

7.  Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer.

Authors:  M K Sauer; I L Andrulis
Journal:  J Med Genet       Date:  2005-08       Impact factor: 6.318

8.  Intrinsic response of thoracic propriospinal neurons to axotomy.

Authors:  Justin R Siebert; Frank A Middelton; Dennis J Stelzner
Journal:  BMC Neurosci       Date:  2010-06-04       Impact factor: 3.288

9.  PI 3 kinase related kinases-independent proteolysis of BRCA1 regulates Rad51 recruitment during genotoxic stress in human cells.

Authors:  Ian Hammond-Martel; Helen Pak; Helen Yu; Raphael Rouget; Andrew A Horwitz; Jeffrey D Parvin; Elliot A Drobetsky; El Bachir Affar
Journal:  PLoS One       Date:  2010-11-17       Impact factor: 3.240

10.  BARD1 participates with BRCA1 in homology-directed repair of chromosome breaks.

Authors:  Ulrica K Westermark; Marsha Reyngold; Adam B Olshen; Richard Baer; Maria Jasin; Mary Ellen Moynahan
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.